Hannah Valantine is a director of BridgeBio Pharma Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BridgeBio Pharma, Inc.
20 Feb 24
144
BridgeBio Pharma, Inc.
15 Feb 24
5
BridgeBio Pharma, Inc.
13 Feb 24
4
BridgeBio Pharma, Inc.
13 Feb 24
4
BridgeBio Pharma, Inc.
18 Jan 24
144
BridgeBio Pharma, Inc.
16 Jan 24
4
BridgeBio Pharma, Inc.
19 Dec 23
144
BridgeBio Pharma, Inc.
15 Dec 23
4
BridgeBio Pharma, Inc.
17 Nov 23
144
BridgeBio Pharma, Inc.
15 Nov 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 24 | BBIO BridgeBio Pharma | Common Stock | Sell | Dispose S | No | Yes | 37.97 | 2,915 | 110.68 k | 1,764 |
16 Jan 24 | BBIO BridgeBio Pharma | Common Stock | Option exercise | Acquire M | No | Yes | 8.45 | 2,915 | 24.63 k | 4,679 |
16 Jan 24 | BBIO BridgeBio Pharma | Stock Option Common Stock | Option exercise | Dispose M | No | No | 8.45 | 2,915 | 24.63 k | 96,176 |
15 Dec 23 | BBIO BridgeBio Pharma | Common Stock | Sell | Dispose S | No | Yes | 36.12 | 2,915 | 105.29 k | 1,764 |
15 Dec 23 | BBIO BridgeBio Pharma | Common Stock | Option exercise | Acquire M | No | Yes | 8.45 | 2,915 | 24.63 k | 4,679 |
15 Dec 23 | BBIO BridgeBio Pharma | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 8.45 | 2,915 | 24.63 k | 99,091 |
15 Nov 23 | BBIO BridgeBio Pharma | Common Stock | Sell | Dispose S | No | Yes | 30 | 2,915 | 87.45 k | 1,764 |
15 Nov 23 | BBIO BridgeBio Pharma | Common Stock | Option exercise | Acquire M | No | Yes | 8.45 | 2,915 | 24.63 k | 4,679 |
15 Nov 23 | BBIO BridgeBio Pharma | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 8.45 | 2,915 | 24.63 k | 102,006 |
21 Jun 23 | BBIO BridgeBio Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 16.75 | 51,501 | 862.64 k | 51,501 |